Aeris Annual Report 2022
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Aeris</strong> Resources Limited<br />
Notes to the consolidated financial statements<br />
30 June <strong>2022</strong><br />
36. Share-based payments (continued)<br />
2021<br />
Balance at Expired/ Balance at<br />
Exercise the start of forfeited/ the end of<br />
Grant date Expiry date price the year Granted Exercised other the year<br />
26/11/2020 30/06/2023 $0.000 - 35,777,281 - - 35,777,281<br />
- 35,777,281 - - 35,777,281<br />
For the performance rights granted during the current financial year, the valuation model inputs used to determine the<br />
fair value at the grant date, are as follows:<br />
Grant date<br />
Expiry date<br />
Share price at<br />
grant date<br />
Exercise price<br />
Expected<br />
volatility<br />
Dividend<br />
yield<br />
Risk-free<br />
interest rate<br />
Fair value at<br />
grant date<br />
25/11/2021 30/06/2024 $0.1632 $0.00 90.922% - 0.950% $0.14<br />
Each Right consists of 4 Tranches (Tranche 1: TSR, 2: Share price, 3: Gold ore reserve and 4: Copper ore reserve). Tranche<br />
1 and 2 were fair valued at $0.12 per share and Tranche 3 and 4 at $0.16 per share.<br />
Management options<br />
Management options (Options) were approved by shareholders at an EGM held on 15 December 2015 with a completion<br />
date of 31 December 2015. The options were issued to ensure that relevant managers remain employed by the Company<br />
to deliver on the Company’s stated business plan and growth strategy.<br />
The Options were granted for no consideration and carry no dividend or voting rights.<br />
When exercisable, each Option is convertible into one ordinary share issued within 10 business days after the Company<br />
receives an exercise notice. The options have a $nil exercise price.<br />
The Options may only be exercised so as to not result in that holder having a voting power in the Company in excess of<br />
19.99%. If a holder is unable to exercise their remaining vested Options the Company must use its best and all reasonable<br />
endeavours to obtain any approval or consent to allow such exercise.<br />
Upon exercise the shares will be subject to a period of voluntary escrow, with the shares being released from escrow in<br />
progressive tranches from the third anniversary of the restructure date (31 December 2015).<br />
Options that have not been exercised will expire 6 years after issue date (31 December 2021), or termination date<br />
whichever is earlier. To the extent the Options have not previously vested, they will be deemed immediately vested upon<br />
a Change of Control Event.<br />
The number of options granted on 15 December 2015 totalled 93,410,609 at a $nil exercise price. As at 30 June 2021 all<br />
options had vested.<br />
The assessed fair value at grant date in circumstances where there is a $nil exercise price, the value per Option on a fully<br />
marketable basis is equal to the value of the underlying share price less dividend ($0.04).<br />
AERIS ANNUAL REPORT <strong>2022</strong><br />
The shares are however subject to various escrow periods and as such a discount for lack of marketability to the Options<br />
was applied to take into consideration the escrow period. A discount for lack of marketability was applied as below:<br />
● 25 % for Tranche 1 ($0.03)<br />
● 20% for Tranche 2 ($0.032)<br />
● 15% for Tranche 3 ($0.034)<br />
● 10% for Tranche 4 ($0.036)<br />
● 0% for Tranche 5 ($0.04)<br />
44<br />
120